Guimei Lin

2.7k citations
86 papers · 2.2k indexed · h-index 27
Topics
Nanoparticle-Based Drug Delivery (27 papers)Nanoplatforms for cancer theranostics (19 papers)RNA Interference and Gene Delivery (11 papers)

In The Last Decade

Guimei Lin

82 papers receiving 2.2k citations

Peers

Guimei Lin
Comparison fields: 5 of 132
  • Biomedical Engineering 927
  • Molecular Biology 894
  • Biomaterials 815
  • Materials Chemistry 229
  • Oncology 199
Replace Shefang Ye with:
Shefang Ye China
Yiping Hu China
Afsana Sheikh India
Jing Su China
Xinru You China
Yan Liang China
Yanyan Jiang China
Haisheng Peng China
Sanjun Shi China
Chunmeng Sun China
Guimei Lin relative to Shefang Ye China Shefang Ye's profile →
Citations per field
00.5×
Shefang Ye · 1×
Citations per year

Countries citing papers authored by Guimei Lin

Since Specialization
Citations

This map shows the geographic impact of Guimei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guimei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guimei Lin more than expected).

Fields of papers citing papers by Guimei Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guimei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guimei Lin. The network helps show where Guimei Lin may publish in the future.

Co-authorship network of co-authors of Guimei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Guimei Lin. A scholar is included among the top collaborators of Guimei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guimei Lin. Guimei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 8
3 11
4 0
5 1
6 1
7 10
8 19
9 34
10 7
11 80
12 27
13 114
14 20
15
Preparation and Evaluation of Propranolol Hydrochloride Liposomal Gel
2
16
Influences of different fertilizer treatments on the yield and quality of wild grape variety Yeniang 2 (Vitis quinquangularis Rehd.).
3
17
Current status of Guangxi water chestnut industrial development and its developing suggestions.
1
18 2
19 32
20
Genetic diversity analysis of banana (Musa spp.) based on ISSR molecular marker.
1

About Guimei Lin

Guimei Lin is a scholar working on Biomaterials, Pharmaceutical Science and Biomedical Engineering, having authored 86 papers that have together received 2.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (27 papers), Nanoplatforms for cancer theranostics (19 papers) and RNA Interference and Gene Delivery (11 papers). The work is most often cited by research in Biomaterials (815 citations), Pharmaceutical Science (170 citations) and Biomedical Engineering (927 citations). Guimei Lin has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Yanbin Shi, Xiaogang Zhao, Leaf Huang, Hong Zhang, Yi Huang, Yongjun Wang, Zhonggui He, Ting Wei, Zili Gu and Tiantian Zuo. Their work appears in journals such as Nature Communications, Nano Letters and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026